Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Renal tubulo-interstitial changes following internal irradiation with alpha particle emitting actinium-225 daughters
    Meeting Abstract

    Seshan, S. V.; Jaggi, J. S.; McDevitt, M. R.; Scheinberg, D. A.
    Modern Pathology (2005)

    Fulltext@MSK | Save
  • Renal tubulo-interstitial changes following internal irradiation with alpha particle emitting actinium-225 daughters
    Meeting Abstract

    Seshan, S. V.; Jaggi, J. S.; McDevitt, M. R.; Scheinberg, D. A.
    Laboratory Investigation (2005)

    Fulltext@MSK | Save
  • Serum HER2 extracellular domain (ECD) levels and efficacy of weekly (W) or every 3-weekly (q3W) paclitaxel (P) with or without trastuzumab (T) in patients (pts) with metastatic breast cancer (MBC): CALGB 150002/9840
    Meeting Abstract

    Seidman, A. D.; Broadwater, G.; Carney, W.; Dressler, L.; Berry, D.; Norton, L.; Hudis, C.; Winer, E.; Ellis, M.; Harris, L.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Androgen deprivation therapy for biochemical recurrence in patients with seminal vesicle invasion after radical prostatectomy
    Meeting Abstract

    Secin, F. P.; Bianco, F. J.; Vickers, A. J.; Sogani, P.; Scher, H. I.; Scardino, P. T.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • A randomized phase II trial comparing two paclitaxel (P)-cisplatin (C) containing chemoradiation (CRT) regimens as adjuvant therapy in resected gastric cancer (RTOG Intergroup #0114)
    Meeting Abstract

    Schwartz, G. K.; Winter, K.; Minsky, B.; Janjan, N.; Schaefer, P.; Thomson, J.; Rani, A.; Gross, H.; Willett, C.; Kelsen, D.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase II trial of erlotinib in patients with bronchioloalveolar carcinoma
    Meeting Abstract

    Sandler, A.; Kris, M.; Miller, V.; Carbone, D.; Pao, W.; Billheimer, D.; Tsao, A.; Patel, J.; Johnson, B.; Johnson, D.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Genetic correction of sickle cell disease by co-regulated gamma-globin transgene expression and beta S interference
    Meeting Abstract

    Samakoglu, S.; Usachenko, Y.; Budak-Alpdogan, T.; Acuto, S.; DiMarzo, R.; Maggio, A.; Tisdale, J.; Riviere, I.; Sadelain, M.
    Blood (2005)

    Fulltext@MSK | Save
  • Randomized phase II trial of cetuximab/bevacizumab/irinotecan (CBI) versus cetuximab/bevacizumab (CB) in irinotecan-refractory colorectal cancer
    Meeting Abstract

    Saltz, L. B.; Lenz, H. J.; Hochster, H.; Wadler, S.; Hoff, P.; Kemeny, N.; Hollywood, E.; Gonen, M.; Wetherbee, S.; Chen, H.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Results of nephrectomy for patients with metastatic renal cancer
    Meeting Abstract

    Russo, P.; Saranchuk, J.; Touijer, K.; Snyder, M. E.; Drucker, B.; Motzer, R.
    Annals of Surgical Oncology (2005)

    Fulltext@MSK | Save
  • Change in circulating endothelial cells (CEC) and tumor cells (CTC) in patients (pts) receiving bevacizumab and erlotinib for metastatic breast cancer (MBC) predicts stable disease at first evaluation
    Meeting Abstract

    Rugo, H. S.; Dickler, M. N.; Scott, J. H.; Moore, D. H.; Melisko, M.; Yeh, B. M.; Caravelli, J.; Brogi, E.; Hudis, C.; Park, J. W.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save